Skip to main content
Top menu links
IMTM Portal
Support cancer research
User account menu
Log in
Language switcher
English
English
Czech
Home
About us
Mission & vision
Management
Administration
Science advisory board
IMTM board
Certificates
Media & PR
Technologies & services
Core facilities
Equipment
Clinical trials
Technologies
Research
Data access committee
Data management plan
Research programs
Research projects
Laboratories and Research groups
Publications
Product pipeline
Mendel-Zirm lectures
Careers
Why the IMTM?
Bachelor
Master
Doctoral
Vacancies
Information for foreigners
Contact
General contacts
Staff
How to find us
Header image
Breadcrumb
Home
Design, Synthesis, and Biological Evaluation of Novel 3-oxo-2,3-dihydropyridazine Derivatives As Interleukin-2-inducible T-cell Kinase (ITK) Inhibitors
Design, synthesis, and biological evaluation of novel 3-oxo-2,3-dihydropyridazine derivatives as interleukin-2-inducible T-cell kinase (ITK) inhibitors
TANGALLAPALLI, S., R. GUNDLA, K. PAIDIKONDALA,
S. GURSKÁ
, N. RAMPEESA, S. ANUGU,
P. DŽUBÁK
,
M. HAJDÚCH
,
V. DAS
, N. KATARI
Design, synthesis, and biological evaluation of novel 3-oxo-2,3-dihydropyridazine derivatives as interleukin-2-inducible T-cell kinase (ITK) inhibitors. RSC advances. 2025, 15(55), 47565-47586, ISSN: 2046-2069, PMID:
41356712
,
PDF
.
